COX-2 inhibitors and the heart: putting risk in perspective

MeSH terms

• Adverse Drug Reaction Reporting Systems
• Anti-Inflammatory Agents, Non-Steroidal / adverse effects
• Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
• Cardiovascular Diseases / chemically induced*
• Cardiovascular Diseases / epidemiology
• Clinical Trials as Topic
• Cyclooxygenase 2 Inhibitors / adverse effects*
• Humans
• Isoxazoles / adverse effects
• Lactones / adverse effects
• Patient Selection
• Product Surveillance, Postmarketing
• Risk Assessment
• Risk Factors
• Stomach Ulcer / chemically induced
• Stomach Ulcer / epidemiology
• Sulfonamides / adverse effects
• Sulfones / adverse effects
• United States / epidemiology
• United States Food and Drug Administration